Prostate MR Solution
End- to-end, AI-powered prostate MRI workflow, from interpretation to biopsy planning
An AI-powered suite of modular applications that streamline prostate MRI interpretation, analysis, and biopsy planning workflows. The solution integrates automated lesion detection and risk classification, intelligent gland segmentation with PSA density calculation, and PI-RADS-compliant reporting into a single platform.
Book a demo
Explore the industry’s most comprehensive integrated portfolio of AI-powered suites of solutions at the European Congress of Radiology.
Enhanced efficiency in prostate cancer diagnosis
Aids detection and characterization of suspicious prostate cancer lesions on MRI with automated ROI candidate identification and per-lesion risk classification at high sensitivity.
Automates PSA density calculation using accurate prostate volume measurements from gland segmentation.
Automatically contours the prostate gland and lesion ROI candidates, providing precise volume measurements while allowing manual refinement when needed.
Supports consistent lesion evaluation and biopsy recommendations for PI-RADS assessment with key findings and sector maps automatically pre-populated in structured reporting.
Compatible with most leading biopsy platforms
From initial scan review to targeted biopsy handoff, the solution connects seamlessly with 11+ fusion biopsy systems, eliminating manual data transfer while supporting radiologists at every step.
Koelis 3D Prostate Suite
MIM Symphony
Surgical BioBot Uro Fusion
Esaote MyLab X9 Fusion
Focal Healthcare
Medcom BiopSee
Navigo
Focalyx
BioJet
Exact Imaging
Proof in practice Evidence, Experience and Resources
27%
more lesions detected (sensitivity improved from 0.48 to 0.61)1
65%
reduction in segmentation variability among radiologists1
15%
improvement in overall radiologist performance1
37%
reduction in workflow time2 for biopsy-recommended
Aprox. 10%
gain in specificity with a biopsy-selective mindset3
>20%
better sensitivity achieved by inexperienced radiologists, when aided by AI vs unaided4
Real voices.
Real impact.
John Melnick, MD
Medical Director, Lenox Hill Radiology
"DeepHealth Prostate makes me faster and more efficient, particularly when l'm looking at harder-to-see areas. I can segment a lesion and push it over to biopsy in an instant."
Radiology AI Suite
One Platform.
Enterprise-wide Impact
Bringing together the broadest portfolio of native clinical AI solutions, intelligent workflow orchestration, and insights on on one cloud-enabled platform. It spans across multiple clinical areas across most of core imaging modalities – MR, CT, X-Ray, mammography and ultrasound – covering triage, detection, assessment, risk prediction and monitoring, with AI findings delivered directly into the worklist, viewer and reporting tools.
For health systems and imaging networks, it replaces a fragmented landscape of single-purpose AI tools with one platform, one partner, one intelligent experience.
Discover Radiology AI Suite[2] Data on file. Kaminer. "Reducing workflow and read-time of prostate MRIs with DeepHealth’s AI-assisted software". Nov 2024.
[3] Data on file. "Evaluating Threshold Modeling in AI-Powered Prostate Cancer Detection." DeepHealth Prostate. 2024.
[4] Faiella et al. "Quantib® Prostate Compared to an Expert Radiologist for the Diagnosis of Prostate Cancer on mpMRI: A Single-Center Preliminary Study." Tomography. August2022.
Disclaimers: DeepHealth Prostate MR Solution comprises multiple applications including DeepHealth Prostate MR and DeepHealth Viewer. DeepHealth Viewer is manufactured by eRAD, Inc. and distributed by DeepHealth, Inc. Any claims made about Prostate MR Solution may reference claims associated with its individual components. Not all products and functionalities are commercially available in all countries.